VIA
ANGO icon

Vident Investment Advisory’s AngioDynamics ANGO Stock Holding History

Vident Investment Advisory’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-63,372
Closed -$1.04M – 1051
2015
Q2 		$1.04M Buy
63,372
+2,881
+5% +$47.8K 0.14% 199
2015
Q1 		$1.08M Buy
+60,491
New +$1.12M 0.22% 120

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Vident Investment Advisory's ANGO Position: Q3 2015 in Review

Vident Investment Advisory sold out of AngioDynamics (ANGO) in Q3 2015, closing a stake of 63,372 shares — an estimated $1.04M sold.

Vident Investment Advisory first reported a position in ANGO in Q1 2015 and held it in 2 quarters. The position peaked at $1.08M in Q1 2015. 117 funds tracked by Wall St. Rank hold ANGO as of Q3 2015.

  • Vident Investment Advisory reported no remaining AngioDynamics position as of Q3 2015 after selling out during the quarter.
  • Vident Investment Advisory sold 63,372 AngioDynamics shares in Q3 2015, an estimated $1.04M.
  • Vident Investment Advisory first reported a position in AngioDynamics in Q1 2015 and held it in 2 quarters.
  • Vident Investment Advisory's AngioDynamics position peaked at $1.08M in Q1 2015.
  • 117 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2015.

Based on Vident Investment Advisory's 13F filing for Q3 2015, filed 26 Oct 2015.